Q3 2018 Holdings
Filed 2018-11-13 | 13 holdings | $23.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $23.4M | 3,061,091 | 99.5% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $28.4K | 1,284,931 | 0.1% |
| Obseva SA | COM | H5861P103 | $20.9K | 1,159,789 | 0.1% |
| Tricida Inc(1T7) | COM | 89610F101 | $19.9K | 650,585 | 0.1% |
| Endocyte Inc | COM | 29269A102 | $10.7K | 600,000 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $8.4K | 327,777 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $8.0K | 2,388,572 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $6.7K | 672,271 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $2.5K | 2,274,370 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $1.8K | 869,538 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $894 | 50,290 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COM | 16383L106 | $493 | 39,036 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $449 | 66,667 | 0.0% |